Purdue Pharma's $225 Million Forfeiture Paves the Way for Settlement Finalization
A judge is anticipated to impose a $225 million forfeiture on Purdue Pharma, the maker of OxyContin, facilitating the completion of its settlement with the Justice Department.
Editorial Staff
1 min read
Updated 18 days ago
On April 21, 2026, a judge is expected to sentence Purdue Pharma, the company behind OxyContin, to forfeit $225 million to the Justice Department.
This forfeiture is a significant step that may allow Purdue Pharma to finalize its settlement, which has been in the works.
The ruling is part of ongoing legal proceedings related to the company's role in the opioid crisis.